Publicaciones en las que colabora con ANGEL SÁNCHEZ RODRÍGUEZ (34)

2012

  1. Four-month history of weakness of lower limbs in a 50-years-old male

    Medicina Clinica, Vol. 138, Núm. 5, pp. 230

2010

  1. Endocarditis secundaria a cateter de derivación ventriculo-atrial

    Anales del sistema sanitario de Navarra, Vol. 33, Núm. 1, pp. 93-95

  2. Increased plasma soluble endoglin levels as an indicator of cardiovascular alterations in hypertensive and diabetic patients

    BMC Medicine, Vol. 8

  3. Therapeutic behavior to follow in the following clinical case: Treatment of type 2 diabetes

    Revista Clinica Espanola

2009

  1. Derrame pleural y artralgias en relación con artritis reumatoide muy evolucionada

    Revista Clinica Espanola, Vol. 209, Núm. 5, pp. 250-251

  2. Effect of different antihypertensive treatments on Ras, MAPK and Akt activation in hypertension and diabetes

    Clinical Science, Vol. 116, Núm. 2, pp. 165-173

2008

  1. Complicaciones macrovasculares del paciente diabético. Pie diabético

    Medicine, Vol. 10, Núm. 17, pp. 1110-1124

  2. Identification of serum endoglin as a novel prognostic marker after acute myocardial infarction: Molecular Diagnosis

    Journal of Cellular and Molecular Medicine, Vol. 12, Núm. 3, pp. 955-961

  3. Síndrome de Wallemberg en paciente joven sin factores de riesgo vascular

    Revista Clinica Espanola

2007

  1. Long-term nebivolol administration reduces renal fibrosis and prevents endothelial dysfunction in rats with hypertension induced by renal mass reduction

    Journal of Hypertension, Vol. 25, Núm. 12, pp. 2486-2496

2005

  1. Relationships between NOS2 and HO-1 in liver of rats with chronic bile duct ligation

    Hepatology Research, Vol. 32, Núm. 1, pp. 58-65

2004

  1. Sequential changes in redox status and nitric oxide synthases expression in the liver after bile duct ligation

    Life Sciences, Vol. 75, Núm. 6, pp. 717-732

2001

  1. Endoglin expression in human and rat mesangial cells and its upregulation by TGF-β1

    Biochemical and Biophysical Research Communications, Vol. 282, Núm. 1, pp. 142-147

  2. Estudio del gen HFE en una familia Española con hemocromatosis hereditaria

    Medicina Clinica, Vol. 116, Núm. 3, pp. 100-103

1999

  1. Antiphosphatidylserine antibodies in patients with autoimmune diseases and HIV-infected patients: Effects of Tween 20 and relationship with antibodies to β2-glycoprotein I

    Journal of Clinical Laboratory Analysis, Vol. 13, Núm. 2, pp. 59-64

  2. Effects of chronic nitric oxide activation or inhibition on early hepatic fibrosis in rats with bile duct ligation

    Clinical Science, Vol. 96, Núm. 3, pp. 297-305

  3. Interaction between prostanoids and nitric oxide in the control of tubular function in rats with chronic bile duct ligation

    Canadian Journal of Physiology and Pharmacology, Vol. 77, Núm. 2, pp. 111-117

  4. Renal function in compensated hepatic cirrhosis: Effects of an amino acid infusion and relationship with nitric acid

    Digestive Diseases, Vol. 17, Núm. 4, pp. 235-240

  5. Unusual toxicity of deferoxamine [4]

    Annals of Pharmacotherapy

1998

  1. Increased nitric oxide synthesis and inducible nitric oxide synthase expression in patients with alcoholic and non-alcoholic liver cirrhosis

    Clinical Science, Vol. 94, Núm. 6, pp. 637-643